Singapore markets open in 4 hours 19 minutes
Straits Times Index
3,292.69 +10.64 (+0.32%) S&P 500
5,018.39 -17.30 (-0.34%) Dow
37,903.29 +87.37 (+0.23%) Nasdaq
15,605.48 -52.34 (-0.33%) Bitcoin USD
57,220.19 -2,681.09 (-4.48%) CMC Crypto 200
1,196.04 -143.02 (-10.68%)
ABT Jan 2025 60.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:14PM EDT. Market open.
| Previous close | 51.20 |
| Open | 51.20 |
| Bid | 52.60 |
| Ask | 56.85 |
| Strike | 60.00 |
| Expiry date | 2025-01-17 |
| Day's range | 51.20 - 51.20 |
| Contract range | N/A |
| Volume | |
| Open interest | 19 |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.